The urgent procurement timeline for French Decree 2026-288
Absorbent hygiene glossary: Terminology from enuresis to menorrhagia
“In a fast-changing regulatory landscape, it is a dangerous strategy to design products only to today’s rules. The French government’s menstrual equity and waste reduction scheme announced in Decree 2026-288 is just the beginning of a move away from single-use consumer products, not the end of it. In this blog I share how I believe you can use the 28-month exclusivity window to position your portfolio for what comes next.”
Outline
-
The Decree 2026-288 exclusivity window in regulatory context
-
Three EU regulatory shifts category leaders are tracking
-
How ESPR treats hygiene products
-
What EmpCo means for on-pack environmental claims
-
Why your supplier choice is your futureproofing strategy
-
Ongoing partnership beyond the 2028 horizon
Key takeaways
The French government’s new period poverty reimbursement scheme applies only to products sold through pharmacies until the end of 2028. This gives pharmacies a unique opportunity to secure market share and a place at the forefront of the reusables revolution. The EU regulatory environment is tightening across single-use plastics, anti-greenwashing and producer responsibility, so the suppliers you choose now will determine your flexibility over the next 24 months.
- The scheme launched on 1 October 2026
- Exclusivity ends 31 December 2028 – plan accordingly
- EmpCo application date and scheme launch are aligned
- Generic green claims will become legally indefensible
- Supplier certification depth determines marketing claim freedom
- Use the 28-month exclusivity to build a defensible position
- Confitex compliance is built for the next cycle
An introduction
Under Decree No. 2026-288, pharmacy networks in France hold exclusivity on the sale and reimbursement of reusable period underwear until 31 December 2028. That gives roughly 28 months of protected channel position before supermarkets and ecommerce become eligible to compete for the same customers.
The question for sourcing managers, category buyers, ESG leads and regulatory affairs teams is what to do with that runway.
The right answer is to use it to lock in the supplier relationships, certifications and marketing claim infrastructure that will carry your private-label range through EU regulatory shifts that are tightening across the same window.
This article sets out the regulatory landscape, the implications for your category, and how to use the exclusivity window strategically.
What the Decree 2026-288 pharmacy exclusivity window buys your business
The exclusivity window is not just commercial protection from supermarkets and ecommerce. It’s also a regulatory and brand-building buffer.
Pharmacy networks who use the window well will emerge in January 2029 with three durable assets that non-specialist channels cannot replicate at speed: established consumer trust in a reimbursed health category, mature supplier relationships built on documented compliance, and a defensible regulatory position against incoming EU rules. Networks who treat the window as routine trading will face commodity competition the moment the channel opens, with none of those assets in place.
The strategic question is ‘what position do we want to hold on 1 January 2029, and what do we need to put in place now to help us get there’.
The EU regulatory shifts category leaders need to track: ESPR and EmpCo
Two pieces of EU regulation will materially reshape the economics and marketing rules of the personal hygiene category in coming years.
The most important regulatory shift is the Ecodesign for Sustainable Products Regulation (ESPR, Regulation (EU) 2024/1781), which gives the European Commission powers to mandate ecodesign requirements – such as durability, reusability, recycled content, substance restrictions and Digital Product Passport obligations – across virtually any product category.
The second is EmpCo, the Empowering Consumers for the Green Transition Directive (Directive (EU) 2024/825). Member States had to transpose it into national law by 27 March 2026, with the rules becoming applicable from 27 September 2026. That date sat almost exactly alongside the French scheme launch on 1 October 2026. From that point, generic environmental claims such as ‘eco-friendly’, ‘sustainable’, ‘green’ or ‘low-impact’ could no longer be made without specific, independently substantiated evidence.
How ESPR applies to reusable period underwear
ESPR does not yet apply to absorbent hygiene products as no delegated act has been adopted for the category. However, the regulation’s framework makes clear the direction of travel, and it is worth understanding what ESPR requirements are likely to look like when AHPs do come into scope.
Under ESPR, the Commission sets product-specific ecodesign requirements. For a category like absorbent hygiene, the requirements most likely to feature are minimum durability and wash-cycle standards, restrictions on intentionally added PFAS and other substances of concern, recycled or bio-based content thresholds, and Digital Product Passport obligations requiring transparent disclosure of material composition, performance data and end-of-life guidance.
Reusable hygiene products – including period underwear – are structurally well-aligned with this anticipated framework. Underwear designed to last 50 or more wash cycles, manufactured without intentionally added PFAS, and supported by independent third-party certification already maps closely onto the durability, substance restriction and transparency criteria that ESPR delegated acts are expected to contain. Disposable AHPs, by contrast, face a more significant design and compliance gap to bridge.
The supplier compliance architecture that satisfies the requirements of the French scheme today (such as wash durability testing, Oeko-Tex Standard 100 Class II and full production-chain traceability) will position your range ahead of the regulatory curve.
What EmpCo means for environmental claims on period underwear
Since 27 September 2026, environmental claims on consumer products must be specific, clear, comprehensible and substantiated by independent verification before they appear on pack, on shelf-talkers, on category pages or in pharmacy training material.
For pharmacy networks selling private-label reusable period underwear, every environmental and sustainability claim has to be supported by documented evidence from an accredited source. Suppliers who cannot provide that documentation expose the private label to regulatory enforcement, consumer authority action and reputational risk.
The implication for procurement teams is direct. The certifications, third-party laboratory reports and chemical-safety evidence that your supplier holds today become the legal foundation for everything you say about the product tomorrow. A supplier whose claims rest on self-assessment is a brand-risk supplier.
Why your supplier choice is your EU regulatory futureproofing strategy
The certifications, the independent test infrastructure and the regulatory documentation your supplier holds in 2026 become the foundation of your defensible marketing claims in 2027, your ESPR case in 2028 and your competitive position when other channels open in 2029.
A supplier whose compliance package is built only to clear the minimum decree threshold leaves you exposed at every regulatory step that follows. A supplier whose compliance package extends well beyond the decree gives you flexibility, headroom and a multi-year competitive moat.
Beyond Decree 2026-288: Ongoing partnership with Confitex Technology
Confitex Technology holds not only the certifications required by Decree 2026-288 (GOTS, OEKO-TEX Standard 100 Class II, independent verification of absorbent performance etc), but also additional certifications that extend regulatory headroom: ISO 13485, MDSAP and the CE Mark for medical devices, OEKO-TEX STeP for environmental and socially responsible practices, GMP for good manufacturing practices and BSCI for socially responsible employment.
Beyond the October 2026 launch, Confitex Technology will support pharmacy and distribution partners with ongoing regulatory consultation, marketing claim substantiation, packaging design and category development support to keep your private-label range competitive across the 2028 exclusivity window and into the post-exclusivity environment.
The compliance package is built to carry partners through the next regulatory cycle, not just the current one.
Next steps: Contact Confitex Technology
How do I get started with Confitex period underwear for the French menstrual equity scheme?
Contact us today to discuss how Confitex Technology reusable period underwear delivers real business outcomes: [email protected]
Find out more about our period underwear on our website.
Read more on this topic in this five-blog series
About the author
Frantisek Riha-Scott, Founder and CEO, Confitex Technology
As the tech leader in reusable personal hygiene since 2013, Confitex designs and manufactures award-winning washable period and incontinence products for leading retail, pharmacy and healthcare brands worldwide. Frantisek has spent more than a decade working at the intersection of fashion design, textile engineering and absorbent hygiene manufacturing, and has worked directly with independent laboratories to shape emerging industry performance standards for reusable absorbent hygiene. His perspective on the French menstrual equity and waste reduction scheme is grounded in detailed working knowledge of the certifications required to trade under Decree 2026-288 and in active conversations with organisations supplying to the scheme. He writes to help pharmacy category managers, hygiene buyers, purchasing directors and procurement leaders cut through the regulatory complexity and make supplier decisions with confidence. Connect with Frantisek on LinkedIn.
